Literature DB >> 14653553

Building the future: psychosocial rehabilitation with a Veterans Construction Team.

Russell K Schutt1, Bernard Cournoyer, Walter E Penk, Charles E Drebing, E Alice Van Ormer, Christopher Krebs, Marylee O Losardo.   

Abstract

The Veterans Construction Team (VCT) is an innovative form of Compensated Work Therapy (CWT) for unemployed, homeless veterans who have had a history of substance abuse and/or a serious mental or medical illness. The VCT model builds social support and self-esteem, while delivering tangible services to public entities and providing a relatively high rate of pay and exceptional opportunities for skill development. This brief report outlines the VCT model, reviews VCTs development and operations, and describes participant reactions. Data were collected by interviewing program managers and office staff, field supervisors and VCT participants, as well as through archival data on VCT projects and VA intake data.

Entities:  

Mesh:

Year:  2003        PMID: 14653553     DOI: 10.2975/27.2003.186.189

Source DB:  PubMed          Journal:  Psychiatr Rehabil J        ISSN: 1095-158X


  3 in total

1.  Psychosocial protective factors and suicidal ideation: Results from a national longitudinal study of veterans.

Authors:  Eric B Elbogen; Kiera Molloy; H Ryan Wagner; Nathan A Kimbrel; Jean C Beckham; Lynn Van Male; Jonathan Leinbach; Daniel W Bradford
Journal:  J Affect Disord       Date:  2019-09-12       Impact factor: 4.839

2.  Protective mechanisms and prevention of violence and aggression in veterans.

Authors:  Eric B Elbogen; Sally C Johnson; Virginia M Newton; Christine Timko; Jennifer J Vasterling; Lynn M Van Male; H Ryan Wagner; Jean C Beckham
Journal:  Psychol Serv       Date:  2014-02-10

3.  Protective factors and risk modification of violence in Iraq and Afghanistan War veterans.

Authors:  Eric B Elbogen; Sally C Johnson; H Ryan Wagner; Virginia M Newton; Christine Timko; Jennifer J Vasterling; Jean C Beckham
Journal:  J Clin Psychiatry       Date:  2012-06       Impact factor: 4.384

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.